What are the signs and symptoms of a sellar mass in an adult patient with a history of subarachnoid hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Signs and Symptoms of Sellar Masses

Sellar masses present with three cardinal symptom categories: hormonal dysfunction (most commonly secondary hormone deficiencies or hyperprolactinemia), mass effect symptoms (particularly visual field defects and headache), or are discovered incidentally on imaging performed for unrelated reasons. 1, 2

Clinical Presentation Patterns

Hormonal Manifestations

  • Secondary hormone deficiencies are the most common presenting feature in clinically manifesting sellar masses, occurring in 29.7% of symptomatic patients 1
  • Hyperprolactinemia is a frequent indication prompting pituitary imaging, particularly in patients with prolactinomas (the most common functioning adenoma) 2
  • Hypogonadism commonly triggers evaluation, with suppressed luteinizing hormone, follicle-stimulating hormone, and sex hormones 2, 3
  • Diabetes insipidus may occur with sellar masses affecting the hypothalamic-pituitary axis, though it is uncommon in nonfunctioning adenomas (only 7% at presentation) 4, 5
  • Hypopituitarism affects 37-85% of patients with nonfunctioning pituitary adenomas, with the GH axis most commonly affected (61-100%), followed by gonadal (36-96%), adrenal (17-62%), and thyroid axes (8-81%) 5

Mass Effect Symptoms

  • Visual field defects occur in 24.2% of clinically manifesting sellar masses and 29.3% of incidentally discovered masses, with bitemporal hemianopsia being characteristic of optic chiasm compression 1, 6
  • Headache is a prominent presenting symptom, particularly when acute or rapidly progressive 3
  • Diplopia and eye pain suggest cavernous sinus involvement or cranial nerve compression 3
  • Acute neurological symptoms may indicate pituitary apoplexy with sudden hemorrhage into the adenoma 4, 7

Pituitary Apoplexy (Specific Context for Subarachnoid Hemorrhage History)

  • Sudden severe headache with acute onset is the hallmark presentation of pituitary apoplexy 4, 7
  • Oculomotor palsies frequently accompany apoplexy due to cavernous sinus involvement 4
  • Hemorrhage from pituitary adenomas can manifest as diffuse subarachnoid hemorrhage, simulating rupture of an anterior cerebral artery aneurysm on CT imaging 7
  • Tumor enlargement, sellar expansion, and intratumoral hemorrhage are characteristic findings on MRI, with T1 signal hyperintensity, low T2 signal, or hemorrhage fluid levels within the pituitary gland 4

Incidental Presentations

  • Neurological complaints (34.2%) are the most common reason for imaging that reveals incidental pituitary masses 1
  • Approximately 47% of pituitary MRI scans performed yield no visible lesion, highlighting the frequency of normal findings 2
  • Incidentally discovered masses are more likely to be macroadenomas (70.7% vs 49.9% in symptomatic masses) 1

Red Flag Symptoms Requiring Urgent Evaluation

  • Rapidly progressive headache with subsequent visual impairment in patients with large sellar masses may indicate aggressive malignancy such as atypical teratoid/rhabdoid tumor 3
  • Acute bilateral blindness can develop post-operatively or from rapid tumor expansion 3
  • Signs of increased intracranial pressure including papilledema warrant immediate assessment 8

Common Pitfalls

  • Empty sella findings (approximately 30% demonstrate some hypopituitarism) should not be dismissed without hormonal screening, though urgent workup is unnecessary in asymptomatic patients 9, 5
  • Attributing headache directly to sellar findings without considering more common primary headache disorders can lead to misdiagnosis 9, 8
  • Missing nonadenomatous lesions is critical, as 18% of visible sellar masses are not adenomas, including Rathke's cleft cysts (19%), craniopharyngiomas (15%), meningiomas (15%), and metastases (5%) 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Pituitary Function Tests: Recommendations and Indications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sellar and Suprasellar Anaplastic Hemangiopericytoma in a 34-Year Old Man.

Annals of clinical and laboratory science, 2017

Guideline

Management of Headache with Partial Empty Sella and Hypodense Gangliocerebellar Lesion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Incidental Partially Empty Sella in a Patient with Headache

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.